About AEGON (AMS:AGN)
Aegon N.V. (Aegon) is an international life insurance, pensions and asset management company. The Company's segments include the Americas, which includes the United States, Mexico and Brazil; the Netherlands; the United Kingdom; Central & Eastern Europe; Spain & Portugal; Asia, and Aegon Asset Management. It offers protection against mortality, morbidity and longevity risks, including traditional and universal life. It offers products with mortality, morbidity, and longevity risks, including traditional and universal life; mortgages; annuity products, and banking products. It offers individual protection products, such as annuities, term insurance, income protection and international/offshore bonds. It has activities in the Czech Republic, Hungary, Poland, Romania, Slovakia and Turkey. It offers life insurance marketed to high-net-worth individuals in Hong Kong and Singapore. It also offers investment products covering third-party customers, insurance-linked solutions.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Drugs - Generic
- Sub-Industry: N/A
- Symbol: AMS:AGN
- CUSIP: N/A
- Web: https://www.aegon.nl
- 50 Day Moving Avg: €210.16
- 200 Day Moving Avg: €229.88
- Trailing P/E Ratio: 5.72
- P/E Growth: 1.03
- Net Margins: 3.97%
- Return on Equity: 8.09%
- Return on Assets: 0.51%
Frequently Asked Questions for AEGON (AMS:AGN)
What is AEGON's stock symbol?
AEGON trades on the AMS under the ticker symbol "AGN."
Who are some of AEGON's key competitors?
Some companies that are related to AEGON include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Kite Pharma (KITE), Omnicare (OCR), VCA (WOOF), NMC Health PLC (NMC), Catalent (CTLT), Valeant Pharmaceuticals Intl (VRX), Health Net (HNT), Patheon NV (PTHN), Mediclinic International PLC (MDC), Puma Biotechnology (PBYI), Alere (ALR) and ConvaTec Group PLC (CTEC).
Who are AEGON's key executives?
MarketBeat Community Rating for AEGON (AMS AGN)MarketBeat's community ratings are surveys of what our community members think about AEGON and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
AEGON's management team includes the folowing people:
- Robert J. Routs, Chairman of the Supervisory Board
- Alexander Rijn Wynaendts, Chief Executive Officer, Chairman of the Executive Board, Chairman of the Management Board
- Mark Bloom, Member of the Management Board, Chief Technology Officer
- Allegra Van Hovell-Patrizi, Member of the Management Board, Chief Risk Officer
- Onno van Klinken, Member of the Management Board, General Counsel
- Carla Mahieu, Member of the Management Board, Global Head Human Resources
- Adrian Grace, Member of the Management Board, Chief Executive Officer of Aegon UK
- Marco B. A. Keim, Member of the Management Board, Chief Executive Officer of Aegon the Netherlands
- Gabor Kepecs, Member of the Management Board, Chief Executive Officer of Aegon Central & Eastern Europe
- Mark Mullin, Member of the Management Board, Chief Executive Officer of Aegon Americas
Consensus Ratings for AEGON (AMS:AGN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for AEGON (AMS:AGN)
Analysts' Ratings History for AEGON (AMS:AGN)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for AEGON (AMS:AGN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for AEGON (AMS:AGN)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for AEGON (AMS:AGN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for AEGON (AMS:AGN)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for AEGON (AMS:AGN)
Latest Headlines for AEGON (AMS:AGN)
Loading headlines, please wait.